Physician profile
Gregory A Lundeen
NPI 1720036270
$301,436.46
in general payments reported to CMS, 2019-2025
36 companies · $49K in 2025
The $49K reported for 2025 was more than what 90% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $53K · 2021: $50K · 2022: $59K · 2023: $11K · 2024: $52K · 2025: $49K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $89K · Travel and Lodging: $15K · Food and Beverage: $7,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $89,400.00 |
| Travel and Lodging | $14,958.73 |
| Food and Beverage | $7,163.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $237,686.96 | 2019-2025 | Salvation, Hoffmann, Prostep |
| Encore Medical, Lp | $33,532.57 | 2021-2025 | |
| Trilliant Surgical LLC. | $20,037.18 | 2021-2025 | 13mm Star E+ Sliding Core Star Total Ankle |
| Medshape, INC. | $4,008.23 | 2021-2025 | Dynanail, Dynanail Helix, Washer, 15 Mm |
| Exactech, INC. | $1,070.23 | 2020-2025 | |
| Goode Surgical INC | $998.08 | 2025 | |
| Bone Support INC. | $527.43 | 2024-2025 | Cerament G, Ceramentbone Void Filler |
| Orthofix Medical, INC. | $297.85 | 2024-2025 | Physio-Stim, Accelstim |
| Zimmer Biomet Holdings, INC. | $226.15 | 2019-2022 | |
| Solventum Corporation | $213.64 | 2024-2025 | V.A.C.Ulta, Prevena, V.A.C. Veraflo |
| Vertex Pharmaceuticals Incorporated | $192.68 | 2024-2025 | |
| Acell, INC. | $192.12 | 2019-2020 | |
| Musculoskeletal Transplant Foundation INC. | $181.81 | 2022-2023 | |
| Treace Medical Concepts, INC. | $176.30 | 2024 | |
| Smith+Nephew, INC. | $175.77 | 2022-2025 | Bone Anchors With Arthroscopic Delivery System |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alafair Biosciences, INC. | $168.65 | 2025 | Versawrap |
| Sequoia Surgical, INC. | $162.27 | 2019-2020 | |
| Curvebeam LLC | $160.37 | 2024 | |
| Davol INC. | $153.27 | 2022 | |
| Avita Medical Americas, LLC | $140.38 | 2025 | Permeaderm, Recell, Cohealyx |
| Kci USA, INC. | $136.68 | 2021-2022 | |
| Kerecis Limited | $134.20 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Amniox Medical, INC. | $133.02 | 2020 | |
| Paragon 28, INC. | $126.66 | 2025 | Additive Orthopedics |
| Biotissue Holdings INC. | $104.80 | 2022-2023 | |
| 3d Systems | $103.18 | 2021 | |
| Linvatec Corporation | $98.01 | 2024 | Biobrace 23mm |
| Baudax Bio INC. | $84.05 | 2021-2022 | |
| Bioventus LLC | $60.92 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $53.86 | 2019 | |
| Polynovo North America LLC | $23.40 | 2024 | Novosorb Btm |
| Arthrex, INC. | $23.15 | 2025 | |
| Si-Bone, INC. | $21.63 | 2023 | |
| Integra Lifesciences Corporation | $16.48 | 2022 | |
| Evolution Surgical, INC | $14.48 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$137,750.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Lundeen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.